Blockchain Registration Transaction Record
Calidi Biotherapeutics Appoints Eric Poma, Ph.D., as CEO to Drive Clinical Development
Calidi Biotherapeutics appoints Eric Poma, Ph.D., as CEO and Board member. Dr. Poma brings 30 years of biotech experience to lead the company's virotherapy platform growth in cancer treatment.

This news matters as the appointment of Dr. Poma as CEO of Calidi Biotherapeutics marks a significant milestone in the company's journey towards advancing its innovative virotherapy platform. With his extensive experience and leadership, the company is poised for growth and progress in the field of cancer treatment. This development underscores the importance of effective leadership in driving forward advancements in biotechnology and oncology.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xd20a1d2ab01e7ec82418f69d135e0dc70985d17fb3117c16ebf070d031281f64 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | seek_FoR-5ee9d0bc44b3b0fc6f1a32877779d327 |